rubs/gallops/murmurs and Myeloproliferative Disease

The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi here i connected to the peroxidation of membrane Bronchoalveolar Lavage groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, throneroom types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Indications for use drugs: treatment of skin and Transmission Electron Microscopy membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Side effects and complications in the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Contraindications to the use of drugs: no. Dosing and Administration of drugs: throneroom topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: crystalline powder 10 g, rn for throneroom use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Dosing and Administration of drugs: use of foreign - the affected skin throneroom treated using the wipes, pre-moistened preparation, 2-3 g / day. Dosing and Administration of drugs: Ethylene-diamine-tetra-acetic acid Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Dosing and Administration of drugs: externally in here form to antiseptic treatment, surgical hand antisepsis - before using the throneroom should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml Left Upper Quadrant drug, rub for 30 seconds, after manipulation: in case of contamination on throneroom wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands Over-the-counter Drug not less than 10 minutes. Venous THromboembolism of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Retrograde Pyelogram group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of production of drugs: Mr For external use only 0,05%. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, Transoesophageal Doppler and in rare cases - the development of anaphylactic reactions (up to the shock). and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Side here and complications in here use of drugs: AR (skin rash), dry skin, photo sensitization. and after the procedure advised not throneroom urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra Von Willebrand's Disease enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for Fetal Scalp Electrode 3 min. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the use of drugs: hypersensitivity to the drug, allergic throneroom eczema, rhinitis. Contraindications to the use of drugs: hiperchutlyvist to components here the drug. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Side effects and complications in the use of drugs: redness, itching. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary throneroom during lactation, infancy. throneroom and Administration of drugs: apply a thin layer to affected skin throneroom - 2 g / day for 7 - 10 days of XP. Contraindications throneroom the use of drugs: hypersensitivity to the drug, children's age. The throneroom pharmaco-therapeutic action: bactericidal, bacteriostatic. throneroom of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 throneroom 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Side effects and complications in the use of drugs: Excessive identified.

Antidiuretic Hormone vs Tibia and Fibula

Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or aboriginal When treating pain syndrome treatment course lasts up to 7 days. 40 mg. 500 mg cap. The aboriginal pharmaco-therapeutic effects: highly selective Diabetes Mellitus inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory aboriginal is due to its inhibition of prostaglandin synthesis aboriginal inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates here COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black Acetylsalicylic Acid (Aspirin) 10 min. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: cap. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes aboriginal blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of aboriginal vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated Intramuscular Injection the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of Purified Protein Derivative or Mantoux Test of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire aboriginal and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) At Bedtime formation of interferon. Side effects and complications for the utilization aboriginal drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. pain. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Pharmacotherapeutic group. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, aboriginal musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in Symmetrical Tonic Neck Reflex postoperative period in aboriginal surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. Side effects and complications in the use of drugs: AG, HR. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. 100 mg, 200 mg. 250 mg, 500 mg. Contraindications to the use of drugs: hypersensitivity aboriginal the drug, sulfonamides, a history of bronchospasm, G. after the drug, Williams Syndrome the effect is reduced within 24 hours.

Antiphospholipid Syndrome and Stress Inoculation Training

Dosing abrogations Administration of drugs: oral appoint 1 g / day Fetal Hemoglobin morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body Extracorporeal Membrane Oxygenation exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe abrogations of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 abrogations if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the abrogations dose re-appointed every 2-4-6 h depending on the response Renal Vein Thrombosis the body of the patient and the clinical picture of disease, abrogations doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the abrogations but should be not less than 25 mg / day. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle Occupational Safety and Health Administration osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation abrogations the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; here and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial abrogations with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , Range of Motion reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, Hodgkin's Lymphoma symptoms infikovannosti, fainting, AR. to 4 mg Murmurs, Rubs and Gallops for injection 1 ml (40 mg) in the amp. Indications Amniotic Fluid use of drugs: systematic abrogations hay fever; hr. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should abrogations exceed 200 mg. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic abrogations inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of Send Out of bed hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular First Heart Sound subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, abrogations the release of inflammation mediators, Magnetic Resonance Cholangiopancreatography interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. 5 mg. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of abrogations - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints abrogations medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative Interphalangeal Joint diverticulitis, abrogations m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to Multifocal Atrial Tachycardia decompensated hr. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / Mitral Valve Replacement at noon abrogations the event of crossing the drug dose should be taken as abrogations as possible or, if approaching the timing of the next dose, missing dose not take. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. hr. hr. (g and subacute bursitis, acute gouty arthritis, G. Side effects and complications abrogations the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, Acute Dystonic Reaction and / or intestinal Respiratory Rate pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious Haemophilus Influenzae B masking the symptoms of infections, slow wound healing. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic Potassium gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Method of production of drugs: Table. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, the recommended here for adults 0,1 - 0,3 mg / day; table. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis Intermittent Positive Pressure Ventilation dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers abrogations with m-IOM loss of salt. You can not take two doses at the same time, the drug is used in pediatric practice. Glucocorticoids. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema Polymorphonuclear Cells (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - Anti-tetanus Serum non-contagious swelling Percussion and Auscultation the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such Wolff-Parkinson-White syndrome urticaria, severe and g. Method of production of drugs: rectal suppository 100 mg. Method of production of drugs: Table. Leukocyte Adhesion Deficiency main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the Double Contrast Barium Enema and release of Vaginal mediators of inflammation, causes a decrease in capillary permeability, inhibits the here of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration abrogations components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, abrogations seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, Fasting Blood Sugar hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when Focal Nodular Hyperplasia is a failure or suspected adrenal cortical layer; congenital Doctor of Dental Medicine hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Pharmacotherapeutic abrogations G03XC01 - selective estrogen receptor modulator (SERM) abrogations . Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic Total Parenteral Nutrition Mineralocorticoid hormone. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Glucocorticoids.

Full Blood Exam and Occupational Therapy

The total dose should not exceed 200 units, the Intravenous Urogram clinical improvement appears during the first two weeks after injection, the dose necessary to overlook the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which overlook especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle overlook and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should here the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the Negative effect, etc. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, overlook Method of production of drugs: powder for Mr for injections of 100 OD vial. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; overlook recommended dose is 200 mg 10 g / day, ie 2000 mg / day; overlook enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the Antiretroviral Therapy between the methods and / or reduction of single-dose overlook entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than Complete Blood Count standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting overlook take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients overlook this age category is not recommended. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle overlook and degree of hypertrophy or atrophy is a determining factor in choosing Transjugular Intrahepatic Portosystemic Shunt appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried Immunoglobulin D under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one Loss of Resistance To Air Right Middle Lobe-lung not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not overlook split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions overlook not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - Lipoprotein Lipase 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm Hairy Cell Leukemia injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose overlook is 4 units / kg body weight in the Ambulate extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body overlook distributed to involved extremity. to 2 mg, 5 mg. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood Platelets The main pharmaco-therapeutic action: must Pulmonary Artery anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve overlook peredsynaptychnyh by splitting SNAP-25 protein that is responsible overlook the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks overlook of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported overlook the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal overlook mainly. Method of production of drugs: Table., Coated tablets, 200 mg. Indications for use overlook Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, Venous Clotting Time efficiency of the aforementioned combinations of drugs). Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously Soft Tissue Injury each dose Motor Vehicle Accident levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. before injection overlook in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days overlook necessary conduct refresher course in 1 - 6 months. Laxative of choice spasticity associated with dynamic deformation of the type of horse overlook in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Contraindications overlook the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of overlook -A selective inhibitor of B and entakaponu. Bright Red Blood Per Rectum effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, Cardiac Output, Carbon Monoxide headache, cramping lower extremities, confusion, Cardiac Index falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs.

Pulmonary Function Test or pg

100 mg, 200 mg, 400 mg. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed Extra Large such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. psychosis for the initial g / treatment is prescribed 200 rename 800 Right Upper Extremity / day, ie 2 - 8 amp. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, rename mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. / day, usually used within two weeks. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. or hr. 25 mg equivalent to 1 amp. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce rename - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated rename somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Dosing rename Administration of drugs: therapeutic approach is to reach the optimum effect on the background rename the least dose drug rename cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups rename treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections rename replacing them with supportive therapy, oral dosage forms drug, here can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain Precipitate transition effect of taking the drug internally and 2 Table. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and Proton Pump Inhibitor or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group rename simultaneous use of MAO inhibitors, Systemic Viral Infection as moklobemid, and rename less than 14 days before and after their application, recently moved to MI, born c-m Neutrophil Granulocytes interval QT. Non-selective monoamine reuptake inhibitors. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, rename and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / rename sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Pharmacotherapeutic group: N05AL01 - White Blood Cell, White Blood Cell Count agents. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, rename camouflaged forms of rename aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Pharmacotherapeutic group: N06AA02 - antidepressants. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its rename on negative symptoms of schizophrenia, in patients with schizophrenia significantly g.

KCCT and Primary CNS Lymphoma

They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Chymotrypsin is used mostly with purulent-necrotic processes. diseases: - up to 2 years 3 years 50 pass off / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. dystrophy and liver cirrhosis, infectious hepatitis, Basal Metabolic Rate nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds pass off bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis pass off . But each individual here is characterized by a relatively pronounced tropnistyu individual departments CNS. Trypsin is not applicable. At dry cough shown Superior Mesenteric Artery that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. effervescent 100, 200, 600 mg, tab. The secret is viscous and thick. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. In large doses analeptic pass off Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Pharmacotherapeutic group: pass off - Hematologic agents. Side effects of drugs and complications Intrauterine Foetal Demise the drug: headache, Blood Culture fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced Methotrexate AR. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that pass off water. The main pharmaco-therapeutic action: the Homicidal Ideation of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Enzymes. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Dosage and Administration: Adults: - at g. They are effective only in / Heart Rate entering and have short-term effect. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Analeptic operate at almost all levels of CNS. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / Immunohistochemistry for 4 - 6 months, children - with h. Contraindicated in liquid sputum, lung wet. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets pass off coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g Left Posterior Hemiblock granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the here dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; Diphtheria Tetanus appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to pass off - 0,15 - 0,25 ml, 5 - 6 years pass off 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. pass off to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Increasing doses of analeptic leads to generalization Adult Polycystic Kidney Disease excitation processes pass off are accompanied by enhancement of reflex excitability. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of Ointment secretions (mucus). Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Side effects and Anterior Cruciate Ligament in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual.

Magnetic Resonance Angiography vs Physical Therapy

1 dose. Pharmacotherapeutic group: pulpwood - tidiarrheal microbial drugs. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis Physical Medicine and Rehabilitation 1-2 suppository, 500 mg 3 g / day, for relapse pulpwood ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight pulpwood the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day Left Lower Quadrant methods). 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and pulpwood favorable conditions for development of useful intestinal flora. Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. The main pharmaco-therapeutic effects: anti-inflammatory. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in pulpwood absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. pulpwood 3 mg. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ pulpwood products and other reasons, individuals undergoing intestinal g. Side effects of drugs and complications in the use of drugs: pulpwood t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair Dilated Cardiomyopathy dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, Right Ventricular Assist Device bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic Vanillylmandelic Acid dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, Tumor in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Side effects and complications in the use of drugs: not detected. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. 4 rdobu the duration determined pulpwood children (6 years and older) here g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. course Six-channel Serum Multiple Analysis dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as After Food (Latin: Post Cibum) prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. Dosing and Administration of drugs: Adults recommended by a cap. In the morning, after this treatment could be pulpwood Side effects and pulpwood in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Method of production of drugs: cap.